Time-dependent changes in rat brain cholinergic receptor expression after experimental brain injury
- PMID: 12542858
- DOI: 10.1089/089771502762300238
Time-dependent changes in rat brain cholinergic receptor expression after experimental brain injury
Abstract
Alterations in neurotransmitter receptor expression in the central nervous system may contribute to physiological and behavioral deficits that follow traumatic brain injury (TBI). Previous studies from our laboratory have demonstrated significant and widespread deficits in alpha7* nicotinic cholinergic receptor (alpha7* nAChr) expression 2 days following cortical contusion brain injury. The purpose of this study was to evaluate changes in alpha7* nAChr expression over a wider range of post-TBI recovery intervals. Animals were anesthetized and subjected to a moderate cortical contusion brain injury (2 mm cortical compression). Animals were euthanatized at various post-TBI time intervals, ranging from 1 h to 21 days, and quantitative autoradiography was used to evaluate cholinergic receptor subtype expression in the cerebral cortex and hippocampus. As previously reported, the alpha7* nAChr was the most sensitive target of TBI-induced plasticity. Significant decreases in alpha-[(125)I]-bungarotoxin (BTX) binding occurred as early as 1 h post-TBI, and persisted in some brain regions for up to 21 days. A kinetic analysis of changes in BTX binding, performed 2 days following brain injury, indicated that the binding deficits are not due to significant changes in receptor affinity. TBI-induced changes in alpha3*/alpha4* nACh receptors, muscarinic cholinergic receptors, and NMDA-type glutamate receptor expression were lower in magnitude, restricted to fewer brain regions and more transient in nature. Persistent deficits in alpha7* nAChr expression following TBI may contribute to impaired functional outcome following brain injury.
Similar articles
-
Chronic nicotine treatment attenuates alpha 7 nicotinic receptor deficits following traumatic brain injury.Neuropharmacology. 2003 Feb;44(2):224-33. doi: 10.1016/s0028-3908(02)00366-0. Neuropharmacology. 2003. PMID: 12623221
-
Traumatic brain injury reduces hippocampal alpha7 nicotinic cholinergic receptor binding.J Neurotrauma. 2000 Nov;17(11):1001-11. doi: 10.1089/neu.2000.17.1001. J Neurotrauma. 2000. PMID: 11101204
-
Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.Neuropharmacology. 2013 Aug;71:228-36. doi: 10.1016/j.neuropharm.2013.03.023. Epub 2013 Apr 11. Neuropharmacology. 2013. PMID: 23583933
-
Traumatic brain injury: central and peripheral role of α7 nicotinic acetylcholine receptors.Curr Drug Targets. 2012 May;13(5):631-6. doi: 10.2174/138945012800398964. Curr Drug Targets. 2012. PMID: 22300031 Review.
-
Alpha-bungarotoxin binding and central nervous system nicotinic acetylcholine receptors.Neuroscience. 1981;6(1):1-14. doi: 10.1016/0306-4522(81)90239-6. Neuroscience. 1981. PMID: 7012663 Review. No abstract available.
Cited by
-
Galantamine and Environmental Enrichment Enhance Cognitive Recovery after Experimental Traumatic Brain Injury But Do Not Confer Additional Benefits When Combined.J Neurotrauma. 2017 Apr 15;34(8):1610-1622. doi: 10.1089/neu.2016.4790. Epub 2016 Dec 20. J Neurotrauma. 2017. PMID: 27806662 Free PMC article.
-
Comparative developmental neurotoxicity of organophosphates in vivo: transcriptional responses of pathways for brain cell development, cell signaling, cytotoxicity and neurotransmitter systems.Brain Res Bull. 2007 May 30;72(4-6):232-74. doi: 10.1016/j.brainresbull.2007.01.005. Epub 2007 Jan 25. Brain Res Bull. 2007. PMID: 17452286 Free PMC article.
-
Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia.Int J Neuropsychopharmacol. 2018 Jul 1;21(7):656-667. doi: 10.1093/ijnp/pyy021. Int J Neuropsychopharmacol. 2018. PMID: 29522184 Free PMC article.
-
Allosterism of Nicotinic Acetylcholine Receptors: Therapeutic Potential for Neuroinflammation Underlying Brain Trauma and Degenerative Disorders.Int J Mol Sci. 2020 Jul 12;21(14):4918. doi: 10.3390/ijms21144918. Int J Mol Sci. 2020. PMID: 32664647 Free PMC article. Review.
-
Targeting α7 nicotinic acetylcholine receptors: a future potential for neuroprotection from traumatic brain injury.Neural Regen Res. 2015 Oct;10(10):1552-4. doi: 10.4103/1673-5374.165309. Neural Regen Res. 2015. PMID: 26692836 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials